Cian Healthcare share news and announcements
BSE: 542678Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹29.77.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹76 Cr4,297th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 21 Sep 2026
- 8.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 21 Sep 2026
- −113.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 21 Sep 2026
- 3.36
- Volume, BSEVolume. Shares traded on the last trading day.
- 685
Cian Healthcare share news and announcements
461 announcements, routine notices left out, newest first. Page 5 of 10.
Sep 2023
Aug 2023
Jul 2023
17 Jul · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
7 Jul · Legal
Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities
Jun 2023
1 Jun · Revised Financials Of Cian Healthcare Limited For March 31, 2023.
May 2023
24 May · Board meeting
Meeting on 30 May 2023: audited results13 May · Announcement under Regulation 30 (LODR)-Meeting Updates
6 May · Intimation Of Facilities Audit Conducted By Sun Pharmaceutical Industries Limited For Procurement Of Indigenous Developed Veterinary Products Pursuant To Regulation 30(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
6 May · Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Intimation Of Receipt Of Registration And Approvals For Export Of Multiple Products Of Company
6 May · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Apr 2023
19 Apr · Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, 2015 For The Year Ended On 31St March, 2023
Mar 2023
Dec 2022
Nov 2022
9 Nov · Board meeting
Meeting on 14 Nov 2022: half yearly results
Oct 2022
13 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 07 Oct · Legal
Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities
Sep 2022
30 Sep · Announcement under Regulation 30 (LODR)-Meeting Updates
23 Sep · Board meeting
Meeting on 26 Sep 20225 Sep · Reg. 34 (1) Annual Report.
3 Sep · Intimation Of Reconstitutions Of Committees Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Aug 2022
Jul 2022
12 Jul · Management
7 Jul · Legal
Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities
May 2022